<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H59680A16470D43D49DC060CF24F5B2FA" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 7208 IH: Medical Supply Chain Security Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-03-24</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 7208</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220324">March 24, 2022</action-date><action-desc><sponsor name-id="G000579">Mr. Gallagher</sponsor> (for himself and <cosponsor name-id="P000607">Mr. Pocan</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to provide enhanced security for the medical supply chain.</official-title></form><legis-body id="H812C959BB350495B9D3D0ED292AE0972" style="OLC"> 
<section id="H8B6FE3EFFBD148528B22322111E29167" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Medical Supply Chain Security Act</short-title></quote>.</text></section> <section id="H2937269E44DE40348BEA0795741AAFDE"><enum>2.</enum><header>Medical supply chain security</header> <subsection id="H06EFC1FA8CB1478BB54BF1F24266F7A4"><enum>(a)</enum><header>Additional manufacturer reporting for essential medical devices</header><text display-inline="yes-display-inline">Section 506C of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/356c">21 U.S.C. 356c</external-xref>) is amended—</text>
<paragraph id="H264A892BC8AA4AD1BEAC9E25AF03476D"><enum>(1)</enum><text>in subsection (a)—</text> <subparagraph id="H24C418BA82F24172BFDE69FB9B5CC39C"><enum>(A)</enum><text>in the matter preceding paragraph (1), by inserting <quote>or device</quote> after <quote>a drug</quote>; and</text></subparagraph>
<subparagraph id="H6A0C9C30C75945B383179235C8BB3417"><enum>(B)</enum><text>in the flush matter by inserting <quote>or device</quote> after <quote>drug</quote> each place such term appears; </text></subparagraph></paragraph> <paragraph id="HFB967AA5E7A74D0AB0525B1086171400"><enum>(2)</enum><text>in subsection (c), by inserting <quote>and devices</quote> after <quote>drugs</quote>;</text></paragraph>
<paragraph id="H58EE389C51BE49EC8397B625EB0AAF8A"><enum>(3)</enum><text>in subsection (g)—</text> <subparagraph id="HDB6356F790E84390BEB24A210987B457"><enum>(A)</enum><text>in the matter preceding paragraph (1), by striking <quote>drug shortage of a drug</quote> and inserting <quote>shortage of a drug or device</quote>;</text></subparagraph>
<subparagraph id="HA8C0795A020745D7A40327F69000D7B1"><enum>(B)</enum><text>in paragraph (1), by striking <quote>; or</quote> and inserting a semicolon;</text></subparagraph> <subparagraph id="H7F145BAF4DD441B584BDD935FB9D266D"><enum>(C)</enum><text>by redesignating paragraph (2) as paragraph (3);</text></subparagraph>
<subparagraph id="H4DA6947C4ECE4859891388141FE43D19"><enum>(D)</enum><text>by inserting after paragraph (1) the following:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="H8105DF79764546C4A6A9F3028994C740"> <paragraph id="H60ABB64BD1914A4689E2AACA239A3489"><enum>(2)</enum><text>expedite the review of a device subject to premarket approval under section 515 that could help mitigate or prevent such shortage; or</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph>
<subparagraph id="H0FCF88C1833D4F699C65D94A53EBB9F6"><enum>(E)</enum><text>in paragraph (3), as so redesignated, by striking <quote>drug shortage</quote> and inserting <quote>shortage</quote>;</text></subparagraph></paragraph> <paragraph id="HF21CD92792094D029E666FB201F33E63"><enum>(4)</enum><text>in subsection (h)—</text>
<subparagraph id="H7DF81C19E28E46B9B08E39720364E376"><enum>(A)</enum><text>by amending paragraph (2) to read as follows:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="H8EF8527DA9EF43BFA5A4BB4E1B1E97E6"> <paragraph id="H4ED1B4D051F145C59B7623303BEC454A"><enum>(2)</enum><text>the term <term>shortage</term>, with respect to a drug or device, means a period of time when the demand or projected demand for the drug or device within the United States exceeds the supply of the drug or device; and</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph>
<subparagraph id="HC53CFB6F052A4C54AD3CC9E2E0DADC5B"><enum>(B)</enum><text>in paragraph (3)(A), by inserting <quote>or device</quote> after <quote>drug</quote>; and</text></subparagraph></paragraph> <paragraph id="HED5BC3BE67B54470BD5151D647183202"><enum>(5)</enum><text>by adding at the end the following:</text>
<quoted-block style="OLC" display-inline="no-display-inline" id="H25EC5D25368849CF88DAF2F3BAFA0273">
<subsection id="H1D5191F39EE04C12B72FEF61C64473BE"><enum>(k)</enum><header>Additional manufacturer reporting for essential drugs and devices</header><text>Each manufacturer of a drug or device described in subsection (a) shall provide to the Food and Drug Administration, on an annual basis, or more frequently at the request of the Secretary, information related to the manufacturing capacity of such drug or device. Such information shall include—</text> <paragraph id="H0E59D28FC4124CCDA60618BD93F16F51"><enum>(1)</enum><text>details about—</text>
<subparagraph id="H8E4C9A3959AC470CA9CE3D2981C7C8C7"><enum>(A)</enum><text>all locations of production;</text></subparagraph> <subparagraph id="H03BD529C3D1A48B693C2752DF6207C0F"><enum>(B)</enum><text>the sourcing of all component parts;</text></subparagraph>
<subparagraph id="H2FA1D5B8A6734530B579A85C8E2A0ADB"><enum>(C)</enum><text>the sourcing of any active pharmaceutical ingredients; and</text></subparagraph> <subparagraph id="HE38B68F29CC64506BCC7D38F78782E8D"><enum>(D)</enum><text>the use of any scarce raw materials; and</text></subparagraph></paragraph>
<paragraph id="HF2F63869F6934EF2A836232760D1FDBD"><enum>(2)</enum><text>any other information determined by the Secretary to be relevant to the security of the supply chain of the drug or device.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection> <subsection id="HF71561A9B92F4266BB0D680E1FD24529"><enum>(b)</enum><header>Provision of additional information</header><text>Section 506C–1 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/356c-1">21 U.S.C. 356c–1</external-xref>) is amended—</text>
<paragraph id="H094810B8A59F4DE6B16548CE3A04007F"><enum>(1)</enum><text>in the heading, by striking <quote><header-in-text style="OLC" level="section">drug shortages</header-in-text></quote> and inserting <quote><header-in-text style="OLC" level="section">drug or device shortages</header-in-text></quote>;</text></paragraph> <paragraph id="H422D46D0C5674256863922B017BAB20E"><enum>(2)</enum><text>by striking <quote>drug shortages</quote> each place it appears and inserting <quote>drug or device shortages</quote>;</text></paragraph>
<paragraph id="H596B54E76AEB466AA73FD5BB19EE7D6E"><enum>(3)</enum><text>in subsection (a)—</text> <subparagraph id="HF028116E60564C1E879BAE210513CDD1"><enum>(A)</enum><text>in paragraph (3)(B)—</text>
<clause id="H21F3A6351EB34FD4B24BA7F7E1A417A2"><enum>(i)</enum><text>in clause (i), by striking <quote>section 506C(g)(1)</quote> and inserting <quote>paragraph (1) or (2) of section 506C(g)</quote>; and</text></clause> <clause id="H5CEC979AF4F54779B6A8BAF53B4B6BD3"><enum>(ii)</enum><text>in clause (ii), by striking <quote>section 506C(g)(2)</quote> and inserting <quote>section 506C(g)(3)</quote>; and</text></clause></subparagraph>
<subparagraph id="H9FCCECFAF8D84FCBA4C3A3E015EE14F2"><enum>(B)</enum><text>in paragraph (5), by striking <quote>drug shortage</quote> and inserting <quote>drug or device shortage</quote>; and</text></subparagraph></paragraph> <paragraph id="H7421C78A81F74410BCAE16142F2EF717"><enum>(4)</enum><text>in subsection (c), by striking <quote><term>drug shortage</term> or</quote>.</text></paragraph></subsection></section> 
</legis-body></bill>

